| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058982A1 Therapeutic agent for gastrointestinal diseases |
| 05/19/2011 | WO2011058943A1 Pharmaceutical composition formed from combining compound having mch r1 antagonist activity and compound having npy y5 antagonist activity |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058474A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 05/19/2011 | WO2011058427A1 Palonosetron metabolites |
| 05/19/2011 | WO2011057872A1 Health-beneficial preparation and production method |
| 05/19/2011 | WO2011057471A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | WO2011024049A3 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations |
| 05/19/2011 | WO2011016937A3 Methods of treatment using thymus-derived compositions |
| 05/19/2011 | WO2010150082A3 Use of chromogranin a and peptidic derivatives thereof in the treatment of inflammation |
| 05/19/2011 | WO2010144140A3 Egfr and par2 regulation of intestinal permeability |
| 05/19/2011 | US20110118825 Anti-angiogenic compositions and methods of use |
| 05/19/2011 | US20110118316 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 05/19/2011 | US20110118307 Compositions and methods for the treatment of infectious diseases |
| 05/19/2011 | US20110118306 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 05/19/2011 | US20110118295 Methods for treating bowel diseases |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118277 Method of treating liver disease |
| 05/19/2011 | US20110118268 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118254 Therapeutic agent for inflammatory bowel disease |
| 05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
| 05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
| 05/19/2011 | US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/19/2011 | US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed |
| 05/19/2011 | US20110118197 Prevention of hepatic ischemic reperfusion injury by administration of sulfatides |
| 05/19/2011 | US20110118195 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/19/2011 | US20110118189 Novel formulations for treatment of migraine |
| 05/19/2011 | US20110118184 Treatments of Gastrointestinal Disorders |
| 05/19/2011 | US20110117217 Method of using guava extract |
| 05/19/2011 | US20110117196 Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects |
| 05/19/2011 | US20110117184 Compositions for mucosal delivery of agents |
| 05/19/2011 | US20110117180 Vegetarian microcapsules |
| 05/19/2011 | US20110117154 Use of rifalazil to treat colonic disorders |
| 05/19/2011 | US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 05/19/2011 | US20110117112 Sodium channel protein type iii alpha-subunit splice variant |
| 05/19/2011 | US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| 05/19/2011 | US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 05/19/2011 | US20110117077 Nutritional composition for infants delivered via caesarean section |
| 05/19/2011 | US20110117075 Thrombin derived peptides for smooth muscle relaxation |
| 05/19/2011 | US20110117068 Probiotic microorganisms for the reduction of manure odor |
| 05/19/2011 | US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
| 05/19/2011 | US20110117059 Composition of soluble indigestible fibre and of microalgae used in the well-being field |
| 05/19/2011 | US20110117053 Method of modulating fibroblast accumulation or collagen deposition |
| 05/19/2011 | US20110117021 Fully human anti-vap-1 monoclonal antibodies |
| 05/19/2011 | DE202010016235U1 Formulierungen Formulations |
| 05/19/2011 | CA2780032A1 Health-promoting composition and preparation method |
| 05/19/2011 | CA2779508A1 Method and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | CA2779417A1 Therapeutic agent for gastrointestinal disease |
| 05/19/2011 | CA2778886A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | CA2777941A1 Nutritional composition for promoting gut microbiota balance and health |
| 05/18/2011 | EP2322933A1 Diagnosis of carcinomas |
| 05/18/2011 | EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |
| 05/18/2011 | EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 05/18/2011 | EP2322222A1 Therapeutic agent for irritable bowel syndrome |
| 05/18/2011 | EP2322218A1 Methods of modulating CD200 receptors |
| 05/18/2011 | EP2322211A1 Live attenuated rotavirus vaccine for oral administration |
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2322190A1 Compositions for bowel cleansing and use thereof |
| 05/18/2011 | EP2322185A2 Polynucleotide therapy |
| 05/18/2011 | EP2322164A2 Carbonylamino derivatives useful for the treatment of inflammatory bowel disease |
| 05/18/2011 | EP2321640A1 Formulation for oral administration of proteins |
| 05/18/2011 | EP2320930A2 Treatment of inflammatory bowel diseases with mammal beta defensins |
| 05/18/2011 | EP1767201B1 Nutrient composition and composition for prevention/mitigation of digestive tract depression |
| 05/18/2011 | EP1662007B1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/18/2011 | EP1558277B1 Treatment of inflammatory bowel disease |
| 05/18/2011 | EP1539664B1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 05/18/2011 | CN1981833B Medicinal composition of elutriate, virgate wormwood herb and and cape-jasmine |
| 05/18/2011 | CN1798831B Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 05/18/2011 | CN102066412A Treatment of diseases and conditions mediated by eicosanoids |
| 05/18/2011 | CN102066396A A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-B]pyridine |
| 05/18/2011 | CN102066359A Novel heteroaryl carboxamide derivatives |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102065872A Probiotics to improve gut microbiota |
| 05/18/2011 | CN102065864A Therapeutic agent for inflammatory bowel disease |
| 05/18/2011 | CN102065825A Oral compositions comprising shellac wax and bleached shellac for use in stomatology and dental care |
| 05/18/2011 | CN102061239A Method for preparing ginkgo, Chinese wolfberry and astragalus health-care wine |
| 05/18/2011 | CN102061238A Manufacturing method of health-preserving and health-care liquor |
| 05/18/2011 | CN102060934A Enzymatic extraction method for auricularia auricula polysaccharides |
| 05/18/2011 | CN102060904A Celosia argentea L. saponin compounds and application thereof |
| 05/18/2011 | CN102060809A Rhein derivatives and preparation and application thereof |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102060786A 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof |
| 05/18/2011 | CN102060732A 5-amino-4-hydroxy-N-aryl azelamide derivatives as well as preparation methods and medical applications thereof |
| 05/18/2011 | CN102060640A Method for preparing diphenyl propane lignan compound |
| 05/18/2011 | CN102058892A Material mixture based on a mixture of ether oils and use of same |
| 05/18/2011 | CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
| 05/18/2011 | CN102058869A Costus qi-regulating gastric-floating preparation and preparation method thereof |
| 05/18/2011 | CN102058867A Costus qi-regulating quick-release preparation and preparation method thereof |
| 05/18/2011 | CN102058866A Aplotaxis carminative soft capsule preparation and preparation method thereof |
| 05/18/2011 | CN102058862A Externally applied medicament for pediatric umbilical part and preparation method thereof |
| 05/18/2011 | CN102058860A Traditional Chinese medicine for treating pig chronic superficial gastritis |
| 05/18/2011 | CN102058858A Medicinal composition for treating acute gastroenteritis and preparation method thereof |
| 05/18/2011 | CN102058850A Application of medicine composition using oil of zedoary turmeric and borneol as raw materials |
| 05/18/2011 | CN102058846A Formula of Traditional Chinese medicine for treating gastritis |
| 05/18/2011 | CN102058844A Traditional Chinese medicine composition for treating gastritis |
| 05/18/2011 | CN102058843A Chinese medicine composition for treating fatty liver |